Back to Index
Jesse Lee Berry, MD
Assistant Professor of Clinical Ophthalmology
DEI 5501 Off Campus Los Angeles
+1 323 442 6578


Dr. Jesse Berry is the Assistant Director of Ocular Oncology at the USC Eye Institute and Children’s Hospital Los Angeles. In addition, Dr. Berry is Associate Residency Program Director for the Los Angeles County + University of Southern California Ophthalmology residency program. She received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center. She then completed a fellowship in ocular oncology at Children’s Hospital Los Angeles under the mentorship of Drs. Kim and Murphree. Dr. Berry is the founder of WOO, Women in Ocular Oncology. Her research endeavors focus on clinical outcomes of retinoblastoma and choroidal melanoma.


Harvard College Scholarship: Elizabeth Cary Agassiz Scholar

Malcolm Kinsberg Scholarship

Kappa Alpha Theta Foundation Scholarship

David Rockefeller Center of Latin American Studies Grant

Nevil & Louise Ford Scholarship Fund

Harvard Medical International Initiatives in Research Grant

Center for Eye Research and Education McCleary Grant

Doheny Eye Institute Medical Knowledge Award

Starr Schulman Fellowship

Department of Health Services Innovation Grant

Society of Heed Fellows

University of Southern California Excellence in Resident Teaching Award

Nevil & Louise Ford Scholarship Fund


Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017 Apr; 64(4). View in: PubMed

Wong BJ, Berry JL. Acute Lymphoblastic Leukemia Relapse Presenting as Optic Nerve Infiltration. JAMA Ophthalmol. 2017 Jan 12; 135(1):e164656. View in: PubMed

Aziz HA, Kim JW, Munier FL, Berry JL. Acute Hemorrhagic Retinopathy following Intravitreal Melphalan Injection for Retinoblastoma: A Report of Two Cases and Technical Modifications to Enhance the Prevention of Retinal Toxicity. Ocul Oncol Pathol. 2017 Jan; 3(1):34-40. View in: PubMed

Berry JL, Cobrinik D, Kim JW. Detection and Intraretinal Localization of an 'Invisible' Retinoblastoma Using Optical Coherence Tomography. Ocul Oncol Pathol. 2016 Apr; 2(3):148-52. View in: PubMed

Zhu D, Berry JL, Ediriwickrema L, Wong K, Lee TC, Murphree AL, Kim JW, Jubran R. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California. Ocul Oncol Pathol. 2015 Dec; 2(2):105-11. View in: PubMed

Browne AW, Dandapani SV, Jennelle R, Stevanovic M, Lee TC, Murphree AL, Kampp TD, Astrahan MA, Kim JW, Berry JL. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling. Brachytherapy. 2015 Sep-Oct; 14(5):718-25. View in: PubMed

Berry JL, Jubran R, Lee TC, Murphree AL, Lee D, Kim JW. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age. Ocul Oncol Pathol. 2015 Feb; 1(2):103-10. View in: PubMed

Berry JL, Dandapani SV, Stevanovic M, Lee TC, Astrahan M, Murphree AL, Kim JW. Outcomes of choroidal melanomas treated with eye physics: a 20-year review. JAMA Ophthalmol. 2013 Nov 1; 131(11):1435-42. View in: PubMed

Berry JL, Cuzzo LM, Bababeygy SR, Quiros PA. Unmet need for corrective eyeglasses: results from a Los Angeles County Hospital survey. Int Ophthalmol. 2012 Jun; 32(3):245-50. View in: PubMed

Lee NG, Berry JL, Lee TC, Wang AT, Honowitz S, Murphree AL, Varshney N, Hinton DR, Fawzi AA. Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro. Invest Ophthalmol Vis Sci. 2011 May; 52(6):3868-73. View in: PubMed

Powered bySC CTSI